geriatric care survivorship intervention for improving the overall health of older adults with stage i-iii breast cancer who have completed curative treatment

Conditions: Anatomic Stage I Breast Cancer AJCC v8; Anatomic Stage II Breast Cancer AJCC v8; Anatomic Stage III Breast Cancer AJCC v8

Summary: this trial studies the effect of a geriatric care survivorship intervention in improving the overall health of older adults who have completed curative treatment for stage i-iii breast cancer. geriatric assessment is the complete examination of an elderly individual, which includes a full valuation of the physical and mental conditions, as well as a check of emotional state. geriatric assessment and survivorship visits after treatment may reduce health burdens and improve the well-being and quality of life of elderly patients with breast cancer. researchers hope to improve the overall health of older adults who have undergone curative treatment for stage i-iii breast cancer.

primary objective: i. determine the feasibility of implementing the geriatric care survivorship intervention in older adults who have completed curative-intent chemotherapy. secondary objectives: i. assess the impact of a geriatric assessment (ga)-guided intervention on patient-reported quality-of-life/physical function (assessed by the functional assessment of cancer therapy-breast \[fact-b\]), geriatric assessment measures (assessed by ga) and objective physical function (assessed by the short physical performance battery \[sppb\]) in older survivors from baseline to 6- and 12-months +/- 4-weeks post-chemotherapy. ii. determine the impact of intervention on patient reported cognitive function (fact-cog) and objective cognitive function (mini-cog) from baseline to 6- and 12-months +/- 4-weeks post-chemotherapy. iii. estimate the effect of the intervention on completion of referral appointments and contacts with primary care providers. iv. estimate the effect of the intervention on emergent healthcare utilization (emergency room \[er\] visits and hospitalizations) at 6- and 12-months +/- 4 weeks post-chemotherapy. v. determine the impact of the intervention on both patient and caregiver satisfaction with care ("health care climate questionnaire") from baseline to 6- and 12-months +/- 4-weeks post-chemotherapy. vi. determine the impact of intervention on caregiver distress ("burden scale for family caregivers") and satisfaction with care ("health care climate questionnaire") from baseline to 6- and 12-months +/- 4-weeks post-chemotherapy. outline: patients complete geriatric assessments at baseline, 6 months, and 12 months later. based on the assessments, patients may receive further intervention at survivorship visit. patients also receive survivorship care educational materials and wear a wearable activity tracking device for 1 year on study.

Eligibility criteria:
inclusion criteria: * \>= 65-years-old * histologically confirmed stage i, ii or iii breast cancer (if the patient has had more than one breast cancer, the most recent diagnosis) * within 8 (+/- 14 days) weeks of completing a chemotherapy regimen for breast cancer either as standard-of-care or on a study (can be receiving concomitant radiation, her-2 targeted agents and/or endocrine therapy) * english or spanish speaking * able to provide written, informed consent * willing and able to meet all study requirement * caregiver eligibility: \>= 18-years-old * caregiver eligibility: ability to complete required study procedures exclusion criteria: * the presence of significant medical conditions that in the physician's (either the patient's primary oncologist of the study principal investigator) judgement preclude participation in the exercise intervention